Change in Estradiol Levels among Premenopausal Patients with Breast Cancer Treated Using Leuprolide Acetate 11.25 Milligrams 3-Month Depot and Tamoxifen

The combination of luteinizing hormone-releasing hormone analogs (LHRHa) with tamoxifen is used as a standard postoperative adjuvant therapy in patients with hormone receptor-positive/premenopausal breast cancer. Long-acting LHRHa formulations offer advantages in terms of patient convenience. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Young-jin, Wu, Zhen-Yu, Kim, Hee jeong, Lee, Jong Won, Chung, Il Yong, Kim, Jisun, Lee, Sae Byul, Son, Byung Ho, Kim, Sung-Bae, Jung, Jae Ho, Gong, Gyungyub, Ahn, Sei-Hyun, Ko, BeomSeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604376/
https://www.ncbi.nlm.nih.gov/pubmed/33154830
http://dx.doi.org/10.4048/jbc.2020.23.e57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604376/
https://www.ncbi.nlm.nih.gov/pubmed/33154830
http://dx.doi.org/10.4048/jbc.2020.23.e57

Ejemplares similares